Beijing Strong Biotechnologies Inc
SZSE:300406
Net Margin
Beijing Strong Biotechnologies Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | CN |
| Market Cap | 10.2B CNY |
| Net Margin |
30%
|
| Country | US |
| Market Cap | 290.3B USD |
| Net Margin |
9%
|
| Country | US |
| Market Cap | 168.9B USD |
| Net Margin |
13%
|
| Country | US |
| Market Cap | 113.4B USD |
| Net Margin |
37%
|
| Country | US |
| Market Cap | 106.7B USD |
| Net Margin |
29%
|
| Country | AU |
| Market Cap | 138.6B AUD |
| Net Margin |
17%
|
| Country | US |
| Market Cap | 84.6B USD |
| Net Margin |
2%
|
| Country | US |
| Market Cap | 50.9B USD |
| Net Margin |
-116%
|
| Country | US |
| Market Cap | 43.1B USD |
| Net Margin |
-33%
|
| Country | US |
| Market Cap | 33.5B USD |
| Net Margin |
12%
|
| Country | KR |
| Market Cap | 40T KRW |
| Net Margin |
25%
|
Profitability Report
View the profitability report to see the full profitability analysis for Beijing Strong Biotechnologies Inc.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Beijing Strong Biotechnologies Inc's most recent financial statements, the company has Net Margin of 30.3%.
You don't have any saved screeners yet
